Serum IL-6 level as a predictor of response to neo-Adjuvant chemotherapy in patients of breast carcinoma
ConclusionsPre-treatment serum IL-6 levels can be considered a good biomarker to predict response to chemotherapy.
Source: Hellenic Journal of Surgery - Category: Surgery Source Type: research
More News: Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Statistics | Study | Surgery